Connor, Clark & Lunn Investment Management Ltd.
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1596800
VANCOUVER, A1
Position in ACRS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,318,850
+$1,002,017 QoQ
Shares Held
1,418,360
-1.1% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. ACRS ranks #35 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
384,681 | $20,280,382 |
All Filings in ACRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,318,850 | 1,418,360 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,316,833 | 1,434,164 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,028,546 | 1,067,656 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,131,930 | 797,134 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,323,466 | 865,011 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,253,871 | 908,819 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $382,266 | 332,406 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $127,138 | 115,580 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $124,958 | 100,773 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $1,378,446 | 201,233 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,186,379 | 210,837 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,429,098 | 176,650 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $265,324 | 16,846 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $422,681 | 26,854 | Shares | Sole | 2022-11-10 | |
| 2020-09-30 | $81,147 | 31,575 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||